Running Point Capital Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.85K | Hold |
135
| – | – | ﹤0.01% | 168 |
|
|
2025
Q1 | $9.53K | Hold |
135
| – | – | ﹤0.01% | 158 |
|
|
2024
Q4 | $8.87K | Hold |
135
| – | – | ﹤0.01% | 145 |
|
|
2024
Q3 | $9.53K | Hold |
135
| – | – | ﹤0.01% | 131 |
|
|
2024
Q2 | $8.95K | Hold |
135
| – | – | ﹤0.01% | 127 |
|
|
2024
Q1 | $9.17K | Buy |
135
+90
| +200% | +$6.11K | ﹤0.01% | 127 |
|
|
2023
Q4 | $2.79K | Buy |
+45
| New | +$2.79K | ﹤0.01% | 148 |
|